ME/CFS and long COVID; negative outcomes for ALS drug; donanemab
Neurology Today in 518 Apr 2024

ME/CFS and long COVID; negative outcomes for ALS drug; donanemab

Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer's disease.

Populært innen Premium

papaya
krimpodden-vg
giver-og-gjengen-vg
avhort
aftenpodden
storefri-med-mikkel-og-herman
tore-og-haralds-podkast
ida-med-hjertet-i-handen
harm-og-hegseth
tusvik-tnne
big-5-med-nils-og-harald-2
topp-3-med-mads-og-rasmus
konspirasjonspodden
podme-krim
alt-fortalt
fastlegen
aftenpodden-usa
popradet
verdens-verste
catrin-steinar-redder-forholdet